Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

European Heart Journal ◽

Ace Inhibition ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Full Dose ◽

European Society Of Cardiology

Evidence-based common sense: the role of clinical history for the diagnosis of vasovagal syncopeThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

European Heart Journal ◽

10.1093/eurheartj/ehi663 ◽

2005 ◽

Vol 27 (3) ◽

pp. 253-254 ◽

Cited By ~ 8

Author(s):

Carlos A. Morillo

Keyword(s):

Common Sense ◽

European Society ◽

European Heart Journal ◽

Clinical History ◽

Evidence Based ◽

European Society Of Cardiology

555 Indirect comparison of the effects of adding an aldosterone antagonist or an angiotensin receptor blocker in severe heart failure: new data from the CHARM-Added trial

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(06)80352-8 ◽

2006 ◽

Vol 5 (1) ◽

pp. 124-124

Author(s):

R WEIR ◽

J MCMURRAY ◽

C GRANGER ◽

B OLOFSSON ◽

J OSTERGREN ◽

...

Keyword(s):

Heart Failure ◽

Indirect Comparison ◽

Severe Heart Failure ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Aldosterone Antagonist

Anxiolytic activity of Angiotensin-Receptor-Blocker in Experimental Models of Anxiety in Mice

Journal of Pharmaceutical Technology Research and Management ◽

10.15415/jptrm.2014.22013 ◽

2014 ◽

Vol 2 (2) ◽

pp. 189-202 ◽

Cited By ~ 1

Author(s):

Syed Rehan Hasan ◽

Manish Sinha ◽

Nitin Bansal

Keyword(s):

Experimental Models ◽

Anxiolytic Activity ◽

Receptor Blocker ◽

Angiotensin-receptor Blocker Therapy – Chronic Kidney Disease and Diabetes

European Cardiology Review ◽

10.15420/ecr.2006.0.2.1q ◽

2006 ◽

Vol 0 (2) ◽

pp. 1

Author(s):

Domenic A Sica ◽

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Blocker Therapy

Effects of Combination of Ace-Inhibitor and Angiotensin Receptor Blocker on Circulating TGF ??1 and Left Ventricular Structure and Function in Hypertensive Patients

High Blood Pressure & Cardiovascular Prevention ◽

10.2165/00151642-200512030-00068 ◽

2005 ◽

Vol 12 (3) ◽

pp. 166

Author(s):

C. Argano ◽

T. Di Chiara ◽

A. Licata ◽

D. Colomba ◽

G. Parrinello ◽

...

Keyword(s):

Ace Inhibitor ◽

Left Ventricular ◽

Structure And Function ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Hypertensive Patients ◽

Left Ventricular Structure ◽

Ventricular Structure ◽

And Function

Effect of Dehydration in the Presence and Absence of the Angiotensin Receptor Blocker Losartan on Blood Constituents in the Camel

Journal of Medical Sciences ◽

10.2174/1996327001104020073 ◽

2011 ◽

Vol 4 (2) ◽

pp. 73-78 ◽

Cited By ~ 1

Author(s):

M. AlHaj

Keyword(s):

Receptor Blocker ◽

Angiotensin Receptor ◽

Blood Constituents ◽

Presence And Absence

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

ESC Heart Failure ◽

10.1002/ehf2.13229 ◽

2021 ◽

Vol 8 (2) ◽

pp. 1438-1445

Author(s):

Bin Wang ◽

Lihua Zhang ◽

Shuang Hu ◽

Xueke Bai ◽

Xi Li ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Receptor Blocker ◽

Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

New England Journal of Medicine ◽

10.1056/nejmoa060838 ◽

2006 ◽

Vol 354 (16) ◽

pp. 1685-1697 ◽

Cited By ~ 659

Author(s):

Stevo Julius ◽

Shawna D. Nesbitt ◽

Brent M. Egan ◽

Michael A. Weber ◽

Eric L. Michelson ◽

...

Keyword(s):

Receptor Blocker ◽

Combined treatment of angiotensin receptor blocker and HMG-CoA reductase inhibitor synergistically improves cardiac dysfunction in Dahl rats

Journal of Molecular and Cellular Cardiology ◽

10.1016/j.yjmcc.2007.07.050 ◽

2008 ◽

Vol 44 (2) ◽

pp. 446-447

Author(s):

Yasuhiro Maejima ◽

Susumu Adachi ◽

Kazuya Isobe ◽

Hiroshi Ito ◽

Mitsuaki Isobe

Keyword(s):

Cardiac Dysfunction ◽

Reductase Inhibitor ◽

Combined Treatment ◽

Receptor Blocker ◽

Angiotensin Receptor ◽

Hmg Coa Reductase ◽

Hmg Coa Reductase Inhibitor ◽

Coa Reductase

Spironolactone and angiotensin receptor blocker in nondiabetic renal diseases

The American Journal of Medicine ◽

10.1016/j.amjmed.2004.04.020 ◽

2004 ◽

Vol 117 (6) ◽

pp. 444-445 ◽

Cited By ~ 14

Author(s):

Kosaku Nitta ◽

Keiko Uchida ◽

Hiroshi Nihei

Keyword(s):

Receptor Blocker ◽

Renal Diseases ◽